Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

EdenTree Amity UK A

Ranked 200 out of 255 in - UK (All Companies) over 12 months
All calculations are in GBP unless stated

Managed by

Ketan Patel

Ketan Patel currently works at EdenTree Investment Management. He began his career on the equity derivatives trading desk at JP Morgan, before moving to Insight Investment as a global healthcare analyst. He has been a CFA Charterholder since 2009, holds an undergraduate degree in History & Geography and post-graduate degrees in both Geography and Economics from the University of London.

Susan Round

Susan Round controls a significant amount of assets for EdenTree Investment Management across a wide range of sectors. Funds under her jurisdiction include the ethically screened Amity unit trust, which invests in British companies and is open to individuals, corporate bodies and charitable groups. Round is also responsible for the the UK Equity Growth fund. For this fund she targets growth companies.

Objective

The Fund aims to achieve long term capital appreciation and a reasonable level of income by investing principally in UK companies. The Amity UK Fund seeks to invest in a portfolio of companies which make a positive contribution to society and the environment through sustainable and socially responsible practices.

Showing fund performance in United Kingdom View performance globally

Performance

UK (All Companies) over : 31/03/2018 - 31/03/2019
  • Rank 200/255 Total Return
  • Rank 140/255 Standard Deviation
  • Rank 173/255 Max Drawdown
Fund Name Currency Return
198 River and Mercantile UK Recovery A GBP

0.1%

199 GVQ Opportunities Fund I GBP

0.0%

200 EdenTree Amity UK A GBP

-0.3%

200 GVQ UK Focus I GBP

-0.3%

202 Artemis Capital R Acc GBP

-0.3%

Total Return

Quarterly Performance

to 31/03/2019 Annual Q1 Q2 Q3 Q4
2019 9.0%
2018 -12.9% -4.8% 7.0% -1.5% -13.2%
2017 11.9% 4.1% 3.6% 1.5% 2.2%
2016 3.6% -1.7% -3.9% 8.7% 0.9%
2015 7.8% 5.1% 2.8% -3.7% 3.6%
2014 1.7% -0.5% -1.0% -1.8% 5.1%
2013 27.4% 11.5% 0.2% 6.5% 7.0%
2012 18.6% 9.5% -1.7% 7.3% 2.7%
2011 -3.0% 0.0% 3.5% -9.4% 3.4%
2010 19.6% 4.9% -5.0% 12.2% 7.1%
2009 28.1% -9.6% 14.6% 19.8% 3.3%
2008 -30.8% -6.9% -7.9% -8.4% -11.9%
2007 -4.1% 4.7% 0.3% -5.0% -3.9%
2006 20.9% 10.0% -3.4% 4.8% 8.7%
2005 16.8% 4.2% 1.3% 4.1% 6.4%
2004 14.7% 4.2% 1.7% 1.5% 6.7%
2003 21.9% -8.1% 18.0% 5.8% 6.2%
2002 -21.2% 5.0% -10.7% -16.1% 0.1%
2001 -8.2% -5.7% 3.8% -15.8% 11.5%
2000 5.0% 1.5% 1.7% 2.4% -0.7%
1999 12.3% 6.2% 2.7% -3.6% 6.7%
1998 1.6% 9.4% -1.0% -12.1% 6.8%
1997 17.3% 4.3% 2.2% 9.5% 0.5%
1996 15.7% 4.6% 3.3% 3.3% 3.7%
1995 18.4% 0.7% 3.9% 8.1% 4.8%
1994 -4.0% -2.3% -6.8% 4.3% 1.1%
1993 19.1% 5.9% 1.7% 3.6% 6.8%
1992 18.6% 3.5% 3.9% -6.8% 18.3%
1991 14.5% 16.4% -2.1% 8.4% -7.4%
1990 -8.0% -2.7% 5.1% -12.9% 3.3%
1989 27.4% 18.1% 6.0% 2.9% -1.1%
1988 8.1% 3.8% -2.9%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/03/2019

Top 10 Holdings

Stock Size
Halma PLC ORD 4.88%
Dechra Pharmaceuticals PLC ORD 4.34%
GBP Cash 3.79%
GlaxoSmithKline PLC ORD 2.69%
Smith & Nephew PLC ORD 2.58%
Next PLC ORD 2.20%
Legal & General Group PLC ORD 2.11%
DS Smith PLC ORD 2.04%
Prudential PLC ORD 2.01%
Marshalls PLC ORD 2.00%
31/03/2019

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date29/02/1988
  • Share Class size24Mn
  • Base currencyGBP
  • ISIN GB0009371310

Purchase Info

  • Min. initial investment200
  • Min. regular additional investment0

Charges

  • Annual management1.50%
  • Initial investment5.00%

Related News

Making it rain: how water funds caught a following tide

While water supply in the developed world is irredeemably associated with regulated monopoly utilities, a huge range of opportunities exist in the sector

GlaxoSmithKline leads FTSE higher on Pfizer tie-up

Fund managers welcome assurances over dividend as GlaxoSmithKline announces plan to hive off consumer healthcare business into joint venture with Pfizer.

The fund managers boosted by Shire bid

Takeover interest from Japan's Takeda sends pharmaceutical group to top of the FTSE 100, boosting fund manager backers.

Sue Round: my 30 years as a female fund manager

Sue Round is one of the UK's more successful women fund managers, recently celebrating her 30-year anniversary managing the Amity UK fund. She says more still needs to be done to unlock latent female talent.

The fund managers hit by Carillion's collapse

Fund managers had been dumping Carillion's stock in their droves last year, but some were still hit by today's collapse.

Profile: how an ethical revolution led to outperformance

Andrew Gilbert says a 72.44% return in 38 months from his most stringent portfolio debases the ‘prejudices’ against ethical investing.

Profile: Parmenion's ethical boss on how ESG led to outperformance

Rising star Andrew Gilbert on how embracing ethical management has rerated sector stocks 

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).